⏳
Showing Q3 2025 data
PFM Health Sciences, LP's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
PFM Health Sciences, LP
•CIK: 1442756•Filing: Q3 2025
**PFM Health Sciences, LP** manages $1.3B across a diversified portfolio of 70 positions. The fund exhibits significant concentration in large-cap healthcare and biotech names, notably holding LLY at $171.8M and THC at $93.7M. Further top allocations include XBI ($71.9M) and AXSM ($64.4M), indicating a strategic focus on growth catalysts within the life sciences sector. This positioning suggests a conviction-driven approach targeting outsized returns in specialized healthcare verticals.
Total AUM
$1.2B
+ $87.3M in options
QoQ Performance
+2.8%
Positions
66
+ 3 options
Top 10 Concentration
51.5%
Latest Filing
Q3 2025
Top Holdings Allocation
LLY
THC
XBI
AXSM
LLY13.8%
THC7.5%
XBI5.8%
AXSM5.2%
MCK4.5%
PEN4.0%
UTH3.2%
ISRG2.8%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other81.2%
Healthcare17.7%
ETF1.1%
🚪 Exited Positionssold since Q2 2025
+7 more exited positions
Changes from Q2 2025
NEW26 new positions
↑16 increased
↓23 decreased
Historical Filings
Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023